You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Klinger RY, Cooter M, Bisanar T, et al. (2019) Intravenous Lidocaine Does Not Improve Neurologic Outcomes after Cardiac Surgery: A Randomized Controlled Trial. Anesthesiology
Klinger RY, James OG, Borges-Neto S, et al. (2018) 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology
Popiel HA, Takeuchi T, Burke JR, et al. (2013) Inhibition of protein misfolding/aggregation using polyglutamine binding peptide QBP1 as a therapy for the polyglutamine diseases. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 440-6
Strittmatter WJ. (2012) Medicine. Old drug, new hope for Alzheimer's disease. Science (New York, N.Y.). 335: 1447-8
Popiel HA, Burke JR, Strittmatter WJ, et al. (2011) The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases. Journal of Amino Acids. 2011: 265084
Heinzen EL, Need AC, Hayden KM, et al. (2010) Genome-wide scan of copy number variation in late-onset Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 69-77
Need AC, Ge D, Weale ME, et al. (2009) A genome-wide investigation of SNPs and CNVs in schizophrenia. Plos Genetics. 5: e1000373
Need AC, Ge D, Weale ME, et al. (2009) Correction: A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia Plos Genetics. 5
Weinberg JB, Volkheimer AD, Mihovilovic M, et al. (2008) Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia. Leukemia. 22: 2184-92
Hamuro L, Zhang G, Tucker TJ, et al. (2007) Optimization of a polyglutamine aggregation inhibitor peptide (QBP1) using a thioflavin T fluorescence assay. Assay and Drug Development Technologies. 5: 629-36